Apyx Medical Corporation to Participate in Upcoming Investor Conferences in September and October
August 22 2019 - 7:30AM
Business Wire
Apyx Medical Corporation, formerly Bovie Medical
Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical
devices and supplies and the developer of its Helium Plasma
Technology, marketed and sold as Renuvion® in the cosmetic surgery
market and J-Plasma® in the hospital surgical market, announced
today that management will participate in the following upcoming
investor conferences:
The 2019 Dougherty Institutional Investor Conference at
the Millennium Hotel in Minneapolis, MN.
- Management will participate in 1x1 meetings on Thursday,
September 5. There will be no formal presentation.
The Cantor Fitzgerald Global Healthcare Conference at the
InterContinental New York Barclay Hotel in New York, NY.
- Management will present on Friday, October 4 at 1:10 p.m.
Eastern Time.
A live audio webcast of the presentation at the Cantor
Fitzgerald Global Healthcare Conference will be provided under the
‘Company Events’ section of the Apyx Medical Corporation investor
relations website at https://apyxmedical.com/investor_relations/.
An archive of the webcast will be available for replay following
the conferences.
About Apyx Medical
Corporation:
Apyx Medical Corporation (formerly Bovie Medical Corporation) is
an advanced energy technology company with a passion for elevating
people’s lives through innovative products in the cosmetic and
surgical markets. Known for its innovative Helium Plasma
Technology, Apyx is solely focused on bringing transformative
solutions to the physicians and patients it serves. The company’s
Helium Plasma Technology is marketed and sold as Renuvion® in the
cosmetic surgery market and J-Plasma® in the hospital surgical
market. Renuvion offers plastic surgeons, fascial plastic surgeons
and cosmetic physicians a unique ability to provide controlled heat
to the tissue to achieve their desired results. The J-Plasma system
allows surgeons to operate with a high level of precision and
virtually eliminating unintended tissue trauma. The Company also
leverages its deep expertise and decades of experience in unique
waveforms through original equipment manufacturing (OEM) agreements
with other medical device manufacturers. For further information
about the Company and its products, please refer to the Apyx
Medical Corporation website at www.ApyxMedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190822005047/en/
Investor Relations Contact:
Westwicke Partners on behalf of Apyx Medical Corporation Mike
Piccinino, CFA investor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Sep 2023 to Sep 2024